Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trials

9 clinical trials for Brain Metastases From Non-small Cell Lung Cancer (NSCLC) across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases — RECRUITING · NA
• Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial — RECRUITING · PHASE2
• Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases — RECRUITING · PHASE2
• Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction — RECRUITING · PHASE2
• Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases — ACTIVE_NOT_RECRUITING
• Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). — COMPLETED · PHASE3
• Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer — NOT_YET_RECRUITING
• Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases — WITHDRAWN · PHASE2
• Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer — COMPLETED · PHASE2

Refine this search